Metal complexes

US10290819B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10290819-B2
Application numberUS-201113994506-A
CountryUS
Kind codeB2
Filing dateDec 13, 2011
Priority dateDec 15, 2010
Publication dateMay 14, 2019
Grant dateMay 14, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to bisimidazolium salts, to novel mono- and biscarbenes derived therefrom, and to metal complexes which contain corresponding mono- and biscarbenes as ligands, to a process for the preparation of the bisimidazolium salts according to the invention, the mono- and biscarbenes according to the invention and to the metal complexes according to the invention, and to the use of the bisimidazolium salts according to the invention, the mono- and biscarbenes according to the invention and to the use of the metal complexes according to the invention.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound of the formula (1a), (2a) or (3a), where the symbols and indices used have the following meanings: M, M′ is on each occurrence, identically or differently, from the group consisting of Fe, Ru, Os, Co, Rh, Ir, Ni, Pd, Pt, Cu, Ag, Au, Ti, Zr, V, Mn, Sc, Cr, Mo and W; R, R′ is, identically or differently independently of one another, hydrogen, straight-chain or branched alkyl having 1-20 C atoms, straight: chain or branched alkenyl having 2-20 C atoms and at least one double bond, straight-chain or branched alkynyl having 2-20 C atoms and at least one triple bond, saturated, partially or fully unsaturated cycloalkyl having 3-10 C atoms, which may be substituted by alkyl groups having 1-10 C atoms, unsubstituted or substituted aryl or aromatic ring system, unsubstituted or substituted heterocycle or heteroaromatic ring system or substituted or unsubstituted aralkyl or heteroaralkyl, where one or both substituents R and R′ may be partially substituted in any desired position or fully substituted by halogen or partially substituted in any desired position by CN or NO 2 , and halogen is selected from F, Cl, Br and I, and where a carbon atom of one or both substituents R and R′ may be replaced by atoms and/or atom groups selected from the group —O—, —C(O)—, —C(O)O—, —S—, —S(O)—, —SO 2 —, —SO 3 —, —N═, —N═N—, —NH—, —NR 1 —, —PR 1 —, —P(O)R 1 —, —P(O)R 1 —O—, —O—P(O)R 1 —O—, and —P(R 1 ) 2 ═N—, where R 1 is unfluorinated, partially or perfluorinated alkyl having 1-6 C atoms, saturated or partially unsaturated cycloalkyl having 3-10 C atoms, unsubstituted or substituted aryl or saturated or unsaturated, unsubstituted or substituted heterocycle; X, X′ is, identically or differently independently of one another, C, CR 2 or N and where R 2 has, identically or differently, the same meaning as R or R′, and where R 2 may be linked to R or R′ to form a 3- to 20-membered ring, and where no radical R or R′ is bonded to X or X′ if X or X′ stands for O or S; A is —CR 4 ═CR 4 —, —CR 4 ═N— or —CR 4 R 5 —CR 4 R 5 — and wherein R 4 and R 5 may be identical or different and have, independently of one another, the same meaning as R or R′ or are a halogen F, Cl, Br, I, where, in the case of carbon, the unit may optionally be interrupted one or more times at any desired position by heteroatoms N, P, O, S; Y, Y′ is, identically or differently independently of one another, CR 6 or N and R 6 has the same meaning as R or R′, or is a bridging unit consisting of one to three bridge atoms; Z, Z′ is, identically or differently independently of one another, CR 8 or N; with the proviso that at least one atom from X, Y, Z and at least one atom from X′, Y′ and Z′ contains, identically or independently of one another, a N atom where R 8 has, identically or differently, the same meaning as R or R′, and where the radicals R 8 of Z and Z′ may be linked to one another with formation of a ring; K, K′ is on each occurrence, identically or differently, a mono-, di- or trianionic ligand, which may be mono-, bi, tri-, tetra-, penta- or hexadentate; L, L′ is on each occurrence, identically or differently, a neutral mono-, bi, tri-, tetra-, penta- or hexadentate ligand; o, o′ is on each occurrence, identically or differently, the number of ligands K or K′ from 0 to 6, where the ligands K and K′ may be identical or different in the case of o greater than 1; p, p′ is on each occurrence, identically or differently, the number of ligands L or L′ from 0 to 6, where the ligands L and L′ may be identical or different in the case of p greater than 1; where o or o′ is selected so that the charge of all ligands K and K′ corresponds to the valence of the metal atom employed, and the sum of o and p or o′ and p′ is dependent on the coordination number of the metal atom employed and the index s and the denticity of the ligand K and L or K′ and L′, where K or K′ may also be weakly coordinating or non-coordinating and, as counterion, balances the charge of the metal complex, where s is an integer from 1 to 3, so that the metal complex contains 1, 2 or 3 biscarbene ligands, which may be identical or different independently of one another, where, depending on the metal atom M and M′, ligand L p , L′ p′ , K o , K′ o′ and steric influences of the biscarbene ligand may also form a very weak or only a coordinative bond to the metal atom, where, in addition, two or more radicals which are bonded to the same atom or to adjacent atoms may form an aromatic, heteroaromatic or aliphatic ring system with one another, and where, in addition, two or more ligands may be connected to one another via a group R or R′ and thus may form a tetradentate ligand system or a polypodal ligand or the groups R and/or R′ may coordinate to M or M′. 2. The compound according to claim 1 , wherein M and M′ are selected, identically or differently on each occurrence, from the group consisting of Fe, Ru, Os, Co, Rh, Ir, Ni, Pd, Pt, Cu, Ag, Au, Ti, Zr, V, Mn, Sc, Cr, Mo and W. 3. The compound according to claim 1 , wherein R and R′ are selected, identically or differently on each occurrence, from the group consisting of straight-chain or branched alkyl having 1-10 C atoms, saturated cycloalkyl having 3-6 C atoms, which may be substituted by alkyl groups having 1-4 C atoms, unsubstituted or substituted aryl or aromatic ring system, unsubstituted or substituted heterocycle or heteroaromatic ring system or substituted or unsubstituted aralkyl or heteroaralkyl, and where a carbon atom of one or both substituents R and R′ may be replaced by —O—; or in that R or R′, if this is coordinated to the metal, stands for a substituted or unsubstituted aralkyl or heteroaralkyl group, in which, in addition, a C atom may be replaced by O, S or NR. 4. The compound according to claim 1 , selected from the compounds of the formulae (1b), (2b) and (3b), where R, R′, R 1 to R 8 , K, K′, L, L′, o, o′, p, p′ and s have the meanings given in claim 1 and the other symbols and indices used have the following meanings: M, M′ is selected on each occurrence, identically or differently, from the group consisting of Ir, Pt and Cu; A is —CR 4 ═CR 4 — or —CR 4 ═N; and Y, Y′ is, identically or differently independently of one another, CR 6 or N. 5. The compound according to claim 1 , selected from the compounds of the formulae (1c), (1d), (2c), (2d) and (3c), where the symbols and indices used have the meanings given in claim 1 and W, W′ is C. 6. The compound according to claim 1 , wherein the ligands K and K′ are selected from the group consisting of hydride, deuteride, F, Cl, Br, I, pseudohalides, azide, trifluorosulfonates, alkylacetylides, aryl- or heteroarylacetylides, alkyl groups, alkylaryl radicals, aryl groups, which may also be bidentate or polydentate, heteroaryl groups, which may also be bidentate or polydentate, hydroxide, cyanide, cyanate, isocyanate, thiocyanate, isothiocyanate, aliphatic or aromatic alcoholates, aliphatic or aromatic thioalcoholates, amides, carboxylates, anionic, nitrogen-containing heterocycles, aliphatic and aromatic phosphides PR 2 − , aliphatic or aromatic selenides SeR − , cyclopentadienyl (Cp), where the cyclopentadienyl groups may be substituted by alkyl substituents, indenyl, where the indenyl radical may be substituted by alkyl substituen

Assignees

Inventors

Classifications

  • Compounds containing elements of Groups 7 or 17 of the Periodic Table · CPC title

  • Organic PV cells · CPC title

  • Electricity · mapped topic

  • H01L51/009Primary

    Electricity · mapped topic

  • C07F1/00Primary

    Compounds containing elements of Groups 1 or 11 of the Periodic Table · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10290819B2 cover?
The present invention relates to bisimidazolium salts, to novel mono- and biscarbenes derived therefrom, and to metal complexes which contain corresponding mono- and biscarbenes as ligands, to a process for the preparation of the bisimidazolium salts according to the invention, the mono- and biscarbenes according to the invention and to the metal complexes according to the invention, and to the…
Who is the assignee on this patent?
Kunz Doris, Gierz Verena, Merck Patent Gmbh
What technology area does this patent fall under?
Primary CPC classification H01L51/009. Mapped technology areas include Electricity.
When was this patent published?
Publication date Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).